Cytosorbents Corporation (CTSO) vs Vyome Holdings, Inc. (HIND)
A side-by-side comparison of Cytosorbents Corporation and Vyome Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTSO
Cytosorbents Corporation
$4.05HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
HIND
Vyome Holdings, Inc.
$1.90HealthcareDelayed quote: Oct 6, 2026, 11:22 AM EDT
Total return — CTSO vs HIND
growth of $100 · dividends reinvested · last 10yCTSO -97.1% (-29.7%/yr)HIND -100.0% (-84.2%/yr)CTSO compounded faster over this window
Log scale — wide-divergence pair
CTSO HIND
CTSO vs HIND: by the numbers
- •HIND is the larger company ($13M vs $13M market cap).
- •Both run net losses; CTSO's is the smaller (-48.94% vs -8716.77% net margin).
- •Both shrank revenue over the past five years; CTSO's decline was smaller (-3.17% vs -60.54% CAGR).
Metrics side by side
Valuation
| Metric | CTSO | HIND |
|---|---|---|
| P/S ratio | 0.34 | 102.80 |
| P/B ratio | N/A | 2.20 |
| FCF yield | N/A | 3.93% |
Profitability
| Metric | CTSO | HIND |
|---|---|---|
| Gross margin | 71.61% | 64.68% |
| Operating margin | -33.37% | -859.22% |
| Net margin | -48.94% | -8716.77% |
| ROE | N/A | -186.95% |
| ROIC | -43.31% | -57.53% |
Growth (annualized)
| Metric | CTSO | HIND |
|---|---|---|
| Revenue CAGR (5Y) | -3.17% | -60.54% |
| Total return CAGR (5Y) | -52.26% | -92.93% |
Frequently asked
- Which has grown faster, CTSO or HIND?
- Neither grew: over the past five years both shrank revenue, with CTSO's decline the smaller — CTSO at a -3.17% CAGR versus HIND at -60.54%.
- How have CTSO and HIND total returns compared?
- Over the past 5 years, CTSO delivered -52.26% and HIND delivered -92.93% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.